Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian share markets open weak
Thu, 13 Jun 09:30 am

All Asian stock markets have opened the day on a weak note with Japan (down 5.3%) and China (down 3.0%) leading the losses. The Indian share markets indices have also opened the day on a weak note. Barring consumer durables, all sectoral indices have opened in the red with stocks in the auto and healthcare space witnessing maximum losses.

The Sensex today is down by around 187 points (1.0%), while the NSE-Nifty is down by around 47 points (0.8%). Mid and small cap stocks have also opened in the red with the BSE Mid Cap and BSE Small Cap indices down by around 0.9% and 0.7% respectively. The rupee is trading at Rs 58.22 to the US dollar.

Barring Pfizer and Fulford India Ltd, MNC Pharma stocks have opened the day on a weak note with Abott India and Sanofi India Ltd leading the losses. As per a leading financial daily, Pfizer Inc has reached a US$2.15 bn settlement with Israel based Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries related to patent infringement on its acid-reflux drug Protonix. As per the terms of settlement, Teva and Sun Pharma will compensate Pfizer's subsidiary Wyeth and Takeda for the losses incurred when two companies launched 'at-risk' generic versions of Protonix prior to the January 2011 expiration of the patent for pantoprazole (the drug's active ingredient). The drug acts to reduce the secretion of stomach acids and is used to treat the effects of gastroesophageal reflux disease. As per the settlement terms, Teva will pay US$ 800 m in 2013 and the remaining US$ 800 m by October 2014, while Sun Pharma will make a full payment of IS$ 550 m in 2013. Of the total, Pfizer will receive 64% of the settlement and its partner Japan's Takeda Pharmaceutical Co, will receive 36% or about US$774 m from the settlement.

Oil and gas stocks have opened the day on a mainly in the red with mixed note with Essar Oil and Castrol leading the losses. As per a leading financial daily, the Gujarat High Court (HC) has quashed a decision of GAIL (India) Ltd to terminate its contract to provide natural gas to Gujarat State Petroleum Corporation (GSPC). The court has further directed GAIL to fix the price for providing the gas from January 1, 2014. It is important to note here that GAIL and GSPC had signed a contract to provide natural gas for the period between 2004 and 2019. As per the contract, the prices for the gas to be provided from January 1, 2014, onwards were to be fixed by the two parties by December 31, 2011. However, the prices could not be fixed by December 31, 2011 because of the uncertainty shown by GAIL in fixing the price by the deadline. Post the deadline GAIL terminated the contract to supply the gas, a decision which was challenged by GSPC at the HC.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Indian share markets open weak". Click here!


Related Views on News

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


Mar 25, 2019 (Close)